Ptc Therapeutics, Inc. · NASDAQ:PTCT

Schmertzler Michael sold 2,500 Ptc Therapeutics, Inc. shares (Form 4)

Traded Oct 7, 2026 · Filed Oct 9, 2026

On Oct 7, 2026, Schmertzler Michael (Director) sold 2,500 Ptc Therapeutics, Inc. shares at an average US$63.39 for US$158K under a trading plan, leaving 1,294,094 shares. Filed Oct 9, 2026 (Form 4).

Sold
2,500 shares
Price
US$63.39 average (US$63.38 to US$63.95)
Value
US$158K
Holding after
1,294,094 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Oct 7, 2026Common StockSale2,447US$63.381,294,147Indirect
Oct 7, 2026Common StockSale53US$63.951,294,094Indirect

Source

View original at SEC

Related